Bigger improvements  

• You can filter the Adherence Report to target specific opportunities and adherence thresholds 

• Plans in the application received a visual makeover; among other things, this should add more clarity for MA-PDPs

• Now, you can now sort by DIR Fees or Estimated Net Revenue while looking at plan comparisons

• The estimated reimbursements listed on plans now subtract DIR fees by default

 

Subtle improvements

Expanded names of Gap Therapy: Statin and Gap Therapy: ACE/ARB
• Updated texts on Live Integration notifications
• Updated in-app help references to reflect 2018 pricing and coverage limits

Did this answer your question?